Synergy between the inositol phosphate responses to transfected human adenosine A1-receptors and constitutive P2-purinoceptors in CHO-K1 cells

Br J Pharmacol. 1995 Aug;115(8):1415-24. doi: 10.1111/j.1476-5381.1995.tb16632.x.


1. The effect of adenosine A1-receptor and P2-purinoceptor agonists on [3H]-inositol phosphate accumulation has been investigated in CHO-K1 cells transfected with the human adenosine A1-receptor. 2. Adenosine receptor agonists stimulated [3H]-inositol phosphate accumulation in CHO-K1 cells with a rank potency order of N6-cyclopentyladenosine (CPA) > 5'-N-ethylcarboxamidoadenosine (NECA) > 2-chloroadenosine > N6-2-(4-aminophenyl) ethyladenosine (APNEA). The responses to both CPA and APNEA were antagonized by the A1 selective antagonist, 1,3-dipropylcyclopentylxanthine (DPCPX) yielding KD values of 1.2 nM and 4.3 nM respectively. 3. ATP, UTP and ATP gamma S were also able to stimulate [3H]-inositol phosphate accumulation in these cells with EC50 values of 1.9 microM, 1.3 microM and 5.0 microM respectively. 2-Methyl-thio-ATP was a weak agonist of this response (EC50 > 100 microM). 4. The [3H]-inositol phosphate response to CPA was completely attenuated by pertussis toxin treatment (24 h; 100 ng ml-1). In contrast, the responses to ATP, UTP and ATP gamma S were only reduced by circa 30% in pertussis toxin-treated cells. 5. The simultaneous addition of CPA and either ATP, UTP or ATP gamma S produced a large augmentation of [3H]-inositol phospholipid hydrolysis. This was due to an increase in the maximal response and was significantly greater than the predicted additive response for activation of these two receptor systems. The synergy was not observed in pertussis toxin-treated cells. 6. No synergy was observed between the [3H]-inositol phosphate responses to histamine and ATP in CHO-K1 cells transfected with the bovine histamine H1-receptor. In these cells the response to histamine was completely resistant to inhibition by pertussis toxin treatment. 7. This study provides a clear demonstration of a synergy between pertussis toxin-sensitive and insensitive receptor systems in a model cell system which is an ideal host for transfected cDNA sequences. This model system should provide a unique opportunity to unravel the mechanisms underlying this example of receptor cross-talk involving phospholipase C.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Chloroadenosine / pharmacology
  • Adenosine / analogs & derivatives
  • Adenosine / pharmacology
  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / pharmacology
  • Adenosine-5'-(N-ethylcarboxamide)
  • Animals
  • CHO Cells
  • Cattle
  • Cells, Cultured
  • Cricetinae
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Drug Synergism
  • Humans
  • Inositol Phosphates / metabolism*
  • Pertussis Toxin
  • Purinergic P1 Receptor Agonists*
  • Purinergic P2 Receptor Agonists*
  • Uridine Triphosphate / pharmacology
  • Virulence Factors, Bordetella / pharmacology
  • Xanthines / pharmacology


  • Inositol Phosphates
  • N(6)-2-(4-aminophenyl)ethyladenosine
  • Purinergic P1 Receptor Agonists
  • Purinergic P2 Receptor Agonists
  • Virulence Factors, Bordetella
  • Xanthines
  • 2-Chloroadenosine
  • adenosine 5'-O-(3-thiotriphosphate)
  • Adenosine-5'-(N-ethylcarboxamide)
  • N(6)-cyclopentyladenosine
  • Adenosine Triphosphate
  • 1,3-dipropyl-8-cyclopentylxanthine
  • Pertussis Toxin
  • Adenosine
  • Uridine Triphosphate